loading...
Del.icio.us
Google
Yahoo MyWeb
Facebook
Ascenta Therapeutics Overview
Ascenta Therapeutics is a privately-held, clinical-stage biopharmaceutical company dedicated to discovering and developing new medicines to stop cancer. Our core technology consists of agents designed to re-establish the natural program of apoptosis that shuts down cell growth and proliferation in abnormal cells. We have a compound in Phase II cancer clinical trials that inhibits the Bcl-2 family...More»
Ascenta Therapeutics is a privately-held, clinical-stage biopharmaceutical company dedicated to discovering and developing new medicines to stop cancer. Our core technology consists of agents designed to re-establish the natural program of apoptosis that shuts down cell growth and proliferation in abnormal cells. We have a compound in Phase II cancer clinical trials that inhibits the Bcl-2 family of proteins and a pipeline that targets Bcl-2, MDM2 and XIAP. Our development team has broad and deep expertise in oncology and is focused exclusively on addressing the unique obstacles and complex challenges cancer brings to drug development.«Less
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 04/2007 | Series C | 50M | Unknown |
Products
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
Profile
OpinionsUser Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Similar Companies
View All Similar »Web Metrics
View All Web Metrics »
| Alexa Rank: | 15950921 |  |
13617442 |
| Yahoo Search Results: | 3,280 | ||
Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.